AUM is a clinical-stage biopharmaceutical company aiming to democratize R&D with a focus on discovering, acquiring, and developing novel therapeutics in oncology. The company holds exclusive worldwide rights in all disease indications for 2 first-in-class technologies with strong composition of matter patents in all major territories. 1) MNK Inhibition and 2) Multi-Kinase Inhibition (PIM/PI3K/mTOR).
AUM utilizes a proprietary partnered AI-augmented platform to systematically discover and develop targeted cancer therapies focused on genetic targets. AUM’s most advanced program is Phase II ready in colorectal cancer, and 2 additional pre-clinical programs have clear pathways to orphan drug designation.
For 2 years in a row, the company has been awarded the Frost & Sullivan Asia-Pacific Biotech Entrepreneurial Company of the Year Award.
Location: Singapore
Employees: 11-50
Total raised: $27M
Founded date: 2018
Investors 1
| Date | Name | Website |
| - | SPRIM Glob... | sprim.net |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 13.10.2021 | Series A | $27M | - | en.prnasia... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 14.07.2023 | Hope For The Challenging Biotech Landscape in Singapore: Q&a... | The biomedical sciences field in Singapore has recently encountered a number of obstacles, with barr... | kr-asia.co... |
| 13.10.2021 | To advance targeted cancer therapies, AUM Biosciences secure... | AUM Biosciences, a Singapore-based global clinical-stage biotech firm, has closed a US $27 million S... | incubees.c... |
| 13.10.2021 | AUM Biosciences Raises USD$27M in Series A Funding | Vishal Doshi, CEO and Co-founder of AUM Biosciences AUM Biosciences, a Singapore-based biotech comp... | finsmes.co... |
| 13.10.2021 | AUM Biosciences announces closing of USD $27Million in a &qu... | SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- AUM Biosciences (AUM) today announced the successful comple... | en.prnasia... |
| 12.10.2021 | Biotech startup AUM Biosciences raises $27 mn from Everlife ... | Biotech startup AUM Biosciences announced on Tuesday it has raised $27 million (around Rs 200 crore)... | vccircle.c... |
| 12.10.2021 | AUM Biosciences announces closing of $27 million in a “Serie... | SINGAPORE and NEW YORK, October 12, 2021 – AUM Biosciences (AUM) today announced the successful comp... | sprim.net/... |
| 12.10.2021 | AUM Biosciences announces closing of $27 million in a "... | NEW YORK and SINGAPORE, Oct. 12, 2021 /PRNewswire/ -- AUM Biosciences (AUM) today announced the succ... | salamancap... |